 |
72 Diseases |  |
11 Trials |
|
11 Trials |  |
447 News |  |
| «12345 |
- ||||||| ondansetron intravenous / Generic mfg., palonosetron intravenous / Generic mfg.
Trial completion: Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients (clinicaltrials.gov) - Jul 4, 2012
P3, N=670, Completed, Sponsor: Helsinn Healthcare SA
Recruiting --> Completed
- |||||||||| palonosetron intravenous / Generic mfg.
New P3 trial: Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting (clinicaltrials.gov) - Mar 29, 2012
P3, N=384, Completed, Sponsor: Samsung Medical Center
- ondansetron intravenous / Generic mfg., dexamethasone injection / Generic mfg., palonosetron intravenous / Generic mfg.
Trial initiation date: Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients (clinicaltrials.gov) - Mar 18, 2012
P2, N=85, Recruiting, Sponsor: Northside Hospital, Inc.
Recruiting --> Completed Initiation date: Jul 2011 --> Feb 2012
- ondansetron intravenous / Generic mfg., dexamethasone injection / Generic mfg., palonosetron intravenous / Generic mfg.
Enrollment open: Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients (clinicaltrials.gov) - Mar 18, 2012
P2, N=85, Recruiting, Sponsor: Northside Hospital, Inc.
Initiation date: Jul 2011 --> Feb 2012 Not yet recruiting --> Recruiting
- ||| ifosfamide / Generic mfg., doxorubicin hydrochloride / Generic mfg.
Trial completion: Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) (clinicaltrials.gov) - Dec 14, 2011
P=N/A, N=51, Completed, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- || dexamethasone / Generic mfg., metoclopramide / Generic mfg., palonosetron intravenous / Generic mfg.
New P3 trial: A clinical trial to investigate metoclopramide, dexamethasone or Aloxi for the prevention of nausea and vomiting occuring more than 24 hours after chemotherapy administration: the MEDEA trial (EUDRACT) - Dec 12, 2011
P3, N=450, Ongoing, Sponsor: VU University Medical Center Amsterdam
- palonosetron intravenous / Generic mfg.
Trial completion: Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy (clinicaltrials.gov) - Nov 14, 2011
P1/2, N=29, Completed, Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Active, not recruiting --> Completed Recruiting --> Completed
- |||||||||| palonosetron intravenous / Generic mfg.
New P3 trial, CINV: Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients (clinicaltrials.gov) - Sep 26, 2011
P3, N=494, Completed, Sponsor: Helsinn Healthcare SA
- cyclophosphamide / Generic mfg., doxorubicin hydrochloride / Generic mfg.
Trial completion: Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer (clinicaltrials.gov) - Sep 14, 2011
P=N/A, N=41, Completed, Sponsor: University of Washington
Recruiting --> Completed Active, not recruiting --> Completed
- Emestop (ramosetron hydrochloride) / Samyang Group
Trial completion, Surgery: Prophylactic Effects of Ondansetron, Ramosetron, and Palonosetron on Patient-Controlled Analgesia Related Nausea and Vomiting After Urologic Laparoscopic Surgery (clinicaltrials.gov) - Aug 14, 2011
P=N/A, N=105, Completed, Sponsor: Yonsei University
Active, not recruiting --> Completed Recruiting --> Completed